Author Question: The reproductive health nurse counsels a 17-year-old woman who is interested in initiating ... (Read 34 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
The reproductive health nurse counsels a 17-year-old woman who is interested in initiating contraception. Which of the following would be a short-term positive outcome of the visit?
 
  A.
  Able to describe how to obtain and use the contraceptive chosen
  B.
  Continued use and pregnancy prevention for 6 months
  C.
  Lack of side effects and complaints about the method after 3 months
  D.
  Voiced satisfaction with this method over 6 months

Question 2

Match the hormones and their functions.
 
  a. Gonadotropin-releasing hormone
  1. ____ Controls the development and function of the adrenal cortex
  b. Somatostatin
  2. _____ Stimulates the maturation of the mammary glands during pregnancy
  c. Adrenocorticotropic hormone
  3. _____ Regulates thyroid hormones
  d. Oxytocin
  4. _____ Also known as growth hormone-inhibiting hormone; inhibits the release of growth hormone
  e. Prolactin
  5. Among other things, it is responsible for developing muscle mass and protein synthesis
  f. Corticotropin-releasing hormone
  6. _____ Appears to provide a protective action by minimizing a maternal immunological rejection that could cause miscarriage
  g. Thyrotropin-releasing hormone
  7. _____ Stimulates the release of follicle-stimulating hormone and luteinizing hormone from the anterior pituitary
  h. Growth hormone
  8. _____ Stimulates uterine contractions and the release of milk from milk ducts during lactation



prumorgan

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

ANS: A
Short-term outcomes include the patient's ability to voice an understanding about the selected contraceptive method, voice an understanding of all information necessary to provide informed consent, and voice a comfort level with the use of the contraceptive method selected. Intermediate and long-term goals include the patient's correct and consistent use of the selected contraceptive method, denial of adverse side effects, continued satisfaction with the selected contraceptive method, and consistent use of the contraceptive method and avoidance of pregnancy for the following year.

Answer to Question 2

ANS:
1:c; 2: e; 3: g; 4:b; 5:h; 6: f; 7:a; 8:d
Gonadotropin-releasing hormone stimulates the release of follicle-stimulating hormone and luteinizing hormone from the anterior pituitary. Somatostatin is also known as growth hormone- inhibiting hormone; it inhibits the release of growth hormone. Adrenocorticotropic hormone controls the development and function of the adrenal cortex. Oxytocin stimulates uterine contractions and the release of milk from milk ducts during lactation. Prolactin stimulates the maturation of the mammary glands during pregnancy. Corticotropin-releasing hormone appears to provide a protective action by minimizing a maternal immunological rejection that could cause miscarriage. Thyrotropin-releasing hormone regulates thyroid hormones. Growth hormone is responsible for developing muscle mass and protein synthesis, among other things.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

For a complete list of videos, visit our video library